BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9598175)

  • 21. CORRELATION BETWEEN C-erbB-2 WITH GASTRIC MUCOSAL ATYPICAL HYPERPLASIA AND GASTRIC CARCINOMA.
    Song B; Yu J; Wu TS
    J Biol Regul Homeost Agents; 2015; 29(2):471-7. PubMed ID: 26122239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk of cancer in chronic inflammatory bowel diseases].
    Fischbach W
    Leber Magen Darm; 1992 May; 22(3):96-101. PubMed ID: 1625513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced precancerous lesions (APL) in the colonic mucosa.
    Naini BV; Odze RD
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):235-56. PubMed ID: 23809243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of serrated polyps in colorectal carcinogenesis.
    Liang JJ; Bissett I; Kalady M; Bennet A; Church JM
    ANZ J Surg; 2013 May; 83(5):325-30. PubMed ID: 23078414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma.
    Roncucci L
    Ital J Gastroenterol; 1992; 24(9):498-501. PubMed ID: 1489980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Jan; 61(2):419-22. PubMed ID: 11212223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flat adenoma: are western colonoscopists careful enough?
    Kobayashi K; Sivak MV
    Endoscopy; 1998 Jun; 30(5):487-9. PubMed ID: 9693899
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis.
    Cruz MD; Ledbetter S; Chowdhury S; Tiwari AK; Momi N; Wali RK; Bliss C; Huang C; Lichtenstein D; Bhattacharya S; Varma-Wilson A; Backman V; Roy HK
    Oncotarget; 2017 Mar; 8(13):20543-20557. PubMed ID: 28423551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum.
    Edhemović I; Snoj M; Kljun A; Golouh R
    Eur J Surg Oncol; 2001 Sep; 27(6):545-8. PubMed ID: 11520087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
    Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
    Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical analysis of nuclear factor, p38, and cyclin D1 proteins in premalignant lesions and carcinomas of the colorectal mucosa].
    Lee SD
    Korean J Gastroenterol; 2008 Dec; 52(6):359-67. PubMed ID: 19096253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-magnification colonoscopy (with videos).
    Tanaka S; Kaltenbach T; Chayama K; Soetikno R
    Gastrointest Endosc; 2006 Oct; 64(4):604-13. PubMed ID: 16996357
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastrointestinal tract - pathology of early cancers].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2010 Oct; 135(5):385-8. PubMed ID: 20976640
    [No Abstract]   [Full Text] [Related]  

  • 35. Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".
    Stevens RG; Pretlow TP; Hurlstone DP; Giardina C; Rosenberg DW
    Cancer Prev Res (Phila); 2008 Aug; 1(3):215-6; author reply 216. PubMed ID: 19138959
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study on the precancerous significance of colon transitional mucosa and dysplastic mucosa].
    Sun BC; Du ZY
    Zhonghua Yi Xue Za Zhi; 1988 Jul; 68(7):398-401. PubMed ID: 3228736
    [No Abstract]   [Full Text] [Related]  

  • 37. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant crypt foci: A review.
    Fenoglio-Preiser CM; Noffsinger A
    Toxicol Pathol; 1999; 27(6):632-42. PubMed ID: 10588543
    [No Abstract]   [Full Text] [Related]  

  • 39. The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential.
    Pilbrow SJ; Hertzog PJ; Linnane AW
    Br J Cancer; 1992 Oct; 66(4):748-57. PubMed ID: 1419617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis.
    Schneider A; Stolte M
    Z Gastroenterol; 1993 Nov; 31(11):653-6. PubMed ID: 8291276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.